Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

Citing sources familiar with the matter, Bloomberg noted that the longest tranche of the sale, a 12-year security, could yield about one percentage point above Treasuries.

The proceeds are earmarked for general corporate purposes, which may include acquisitions, debt repayment, working capital, capital expenditures, or share repurchases, the source told Bloomberg.

On Monday, five issuers collectively raised $4.5 billion, pushing the month's total issuance past $200 billion. This marks the second strongest month for U.S. investment-grade issuance outside the Covid-19 pandemic ...